Interview | WAMJ UPDATE

Biotech Company's Innovative Drug Gives Cancer Patients Hope as New Therapy for Oral Mucositis

Enzychem Lifesciences recently announced positive results for its lead compound EC-18 in chemoradiation-induced oral mucositis (CRIOM)...

Eul-Sik Yoon, M.D., Ph.D., Chairman, Korean Society of Plastic and Reconstructive Surgeons

As a renowned plastic surgeon and respected member of the medical community, please share with our readers what motivated you to become a...

ISSUE 25

FROM THE PUBLISHER If you're a fan of Korean dramas, chances are you've come across the Netflix series "Squid Game," which has captivated...

Latest Update for Surgical Treatment of Lymphedema

1. Introduction Lymphedema is a chronic, progressive condition caused by insufficient lymphatic drainage and the subsequent stasis of...

Innovative Value-Based Price Programs Back in the Spotlight

Value-based plans are emerging as particularly attractive coverage options for therapies that become available after an FDA accelerated...

Issue25

Europe IMCAS World Congress 2022 January 27-29, 2022 | Paris, France Website: http://imcas2022.com/ Contact: info@imcas2022.com IMCAS...

Upper Middle-Income Countries Left Out by New Merck/Ridgeback COVID-19 Antiviral Licensing Deal

As Merck (NYSE:MRK) and Ridgeback Biotherapeutics sign on to a licensing deal to expand global use of their COVID-19 capsule...

Issue25

October 2021 - December 2021 Israel to Share Data with Pfizer in Exchange for COVID-19 Vaccine Doses Merck Says Antiviral Pill Is...

Issue24

July 2021 - September 2021 FDA Revises Labeling of Biogen’s Alzheimer’s Drug to Emphasize Early Treatment The Food and Drug...

Issue24

North America 2021 JAX Healthcare Forum October 27-28, 2021 | Virtual Conference Website: https://www.jax.org/education-and-learning/educ...

Subscribe to Our Journal